Perspective Therapeutics (CATX) Long-Term Deferred Tax (2011 - 2015)
Perspective Therapeutics (CATX) reported Long-Term Deferred Tax of $46541.0 for Q2 2015, up 15.43% on a YoY basis from $40320.0 in Q2 2014, and up 15.43% sequentially from $40320.0 in Q2 2014.
Perspective Therapeutics (CATX) Long-Term Deferred Tax (2011 - 2015) Analysis & Trends
Perspective Therapeutics (CATX) has 4 years of Long-Term Deferred Tax data on file, last reported at $46541.0 in Q2 2015.
- For the quarter ending Q2 2015, Long-Term Deferred Tax rose 15.43% year-over-year to $46541.0; the trailing twelve-month figure through Jun 2015 stood at $46541.0 (up 15.43% YoY), and the FY2015 full-year result was $46541.0, up 15.43% from the prior year.
- Long-Term Deferred Tax climbed to $46541.0 in Q2 2015, from $40320.0 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $98435.0 in Q2 2012 to a low of $40320.0 in Q2 2014.
- A 4-year average of $64821.0 and a median of $60264.5 in 2011 frame the typical range for Long-Term Deferred Tax.
- Across the five-year window, Long-Term Deferred Tax soared 33.04% in 2012 and advanced 15.43% in 2015, its largest moves.
- Tracing CATX's Long-Term Deferred Tax over 4 years: stood at $73988.0 in 2011, then soared by 33.04% to $98435.0 in 2012, then sank by 59.04% to $40320.0 in 2014, then increased by 15.43% to $46541.0 in 2015.
- Business Quant data shows CATX's Long-Term Deferred Tax at $46541.0 in Q2 2015, $40320.0 in Q2 2014, and $98435.0 in Q2 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 46,541.00 |
| Jun 30, 2014 | 40,320.00 |
| Jun 30, 2012 | 98,435.00 |
| Jun 30, 2011 | 73,988.00 |